Revealing New Advancements in Anesthesia and Patient Monitoring
Continuing to lead the way with cutting-edge innovations in anesthesia delivery and patient monitoring, Spacelabs Healthcare will reveal an array of new products in Booth #42 at WCA, March 25-30 in Buenos Aires, including:
- Arkon™ – High-performance anesthesia delivery system designed to work the way anesthesiologists work – so that the focus is on the patient, not the machine (Pending 510(k) – Not for Sale in USA.)
- BleaseFocus – An anesthesia delivery system that combines versatility with performance, BleaseFocus offers a flexible, open platform that enables you to configure it to suit your requirements and budget
- qube™ – Inspired by the revolutionary style of Xprezzon™, qube breaks with tradition to offer a fresh, new perspective in compact monitoring. (Pending 510(k) – Not for Sale in USA.)
- AriaTele™ – Feature-rich telemetry transmitters delivering high performance and style (Pending 510(k) – Not for Sale in USA.)
"WCA presents a unique opportunity to demonstrate Spacelabs' wide array of perioperative solutions to anesthesiologists worldwide," said Nicholas Ong, President of Spacelabs Healthcare.
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc.(www.spacelabshealthcare.com), a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company's expectations, goals or intentions about the future, including, but not limited to, statements regarding the performance of the Company's products. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.
Contacts:
Spacelabs Healthcare, Inc.
Ross Garland, 425-657-7200 x4000
ross.garland@spacelabs.com
